A detailed history of Shell Asset Management CO transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 17,554 shares of CHRS stock, worth $25,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,554
Previous 15,069 16.49%
Holding current value
$25,102
Previous $26,000 30.77%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$0.99 - $1.8 $2,460 - $4,473
2,485 Added 16.49%
17,554 $18,000
Q1 2024

Jul 31, 2024

SELL
$2.02 - $3.14 $1,779 - $2,766
-881 Reduced 5.52%
15,069 $26,000
Q1 2024

May 14, 2024

SELL
$2.02 - $3.14 $270 - $420
-134 Reduced 0.83%
15,950 $38,000
Q4 2023

Feb 14, 2024

SELL
$1.59 - $3.85 $7,679 - $18,595
-4,830 Reduced 23.09%
16,084 $54,000
Q3 2023

Nov 08, 2023

SELL
$3.74 - $5.45 $1,230 - $1,793
-329 Reduced 1.55%
20,914 $78,000
Q2 2023

Jul 28, 2023

SELL
$3.79 - $8.3 $462 - $1,012
-122 Reduced 0.57%
21,243 $91,000
Q1 2023

May 15, 2023

SELL
$5.89 - $10.52 $441 - $789
-75 Reduced 0.35%
21,365 $146,000
Q4 2022

Feb 07, 2023

SELL
$5.69 - $10.07 $24,768 - $43,834
-4,353 Reduced 16.88%
21,440 $170,000
Q3 2022

Nov 14, 2022

SELL
$7.17 - $13.87 $48,469 - $93,761
-6,760 Reduced 20.77%
25,793 $248,000
Q2 2022

Aug 09, 2022

BUY
$5.86 - $13.23 $322 - $727
55 Added 0.17%
32,553 $236,000
Q1 2022

May 04, 2022

SELL
$10.92 - $16.41 $52,514 - $78,915
-4,809 Reduced 12.89%
32,498 $420,000
Q4 2021

Feb 09, 2022

BUY
$15.81 - $18.99 $2,829 - $3,399
179 Added 0.48%
37,307 $595,000
Q3 2021

Nov 04, 2021

SELL
$12.68 - $17.79 $20,288 - $28,464
-1,600 Reduced 4.13%
37,128 $597,000
Q2 2021

Aug 12, 2021

BUY
$12.95 - $15.41 $27,195 - $32,361
2,100 Added 5.73%
38,728 $536,000
Q1 2021

May 10, 2021

BUY
$14.42 - $21.39 $271,946 - $403,394
18,859 Added 106.13%
36,628 $535,000
Q4 2020

Feb 16, 2021

BUY
$16.56 - $18.94 $294,254 - $336,544
17,769 New
17,769 $309,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $111M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.